Latest News

Evotec goes for massive IPO on Nasdaq

bfishadow via flickr (CC BY 2.0)


by um

German drug discovery company Evotec plans to raise US$576m on the US-American stock exchange Nasdaq to finance extensive investments.

The Hamburg-based company announced that it has commenced a public offering in the USA of up to 22,000,000 American Depositary Shares. The price of the ADS on offer will be determined on the basis of the closing price of Evotec’s shares on the Frankfurt Stock Exchange, where the company has been listed since 2009, using an ADS to share ratio of 2 to 1.

With the money, Evotec plans to finance large-scale investments: On the one hand, it will expand its biologics manufacturing capacity in the USA and build additional capacity in its Toulouse, France, site. A portion of the funds will go towards expanding its precision medicine platform, accelerating its pipeline activities, and expanding its portfolio of investments.

Evotec has applied to list on the Nasdaq Global Select Market under the symbol “EVO”.

Switzerland shows sustained growth of biotech sector

Capital investments in Swiss biotech companies reached the second-best amount ever with CHF3.33bn in the second year of the pandemic, according to...

Sanofi and IGM Biosciences Inc. in $6.15bn deal

Under the agreement, IGM Biosciences Inc. (Mountain View) will discover IgM antibody agonists against three oncology targets and...

TargED Biopharmaceuticals BV raises €39m in Series A financing

Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures  participated in the financing. Seed investors FIRST...

Evotec and BMS intensify R&D on protein degraders

Evotec signs contracts with Almirall and Sernova

Under the alliance Evotec is set to discover novel targets or therapeutics for skin diseases such as atopic dermatitis or basal cell carcinoma....

EU starts consultation on novel plant breeding methods

he EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture. A study commissioned by the...

Finnish VTT spin-out Onego Bio Ltd raises €10m

Venture capital investors Agronomics Limited and Maki VC led the seed financing that is set to solve one of the most presssing environmental problems...